Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2011

01-02-2011 | Healthcare Policy and Outcomes

Extent of Gastric Resection Impacts Patient Quality of Life: The Dysfunction after Upper Gastrointestinal Surgery for Cancer (DAUGS32) Scoring System

Authors: Misuzu Nakamura, RN, PhD, Yoshinori Hosoya, MD, PhD, Masahiko Yano, MD, PhD, Yuichiro Doki, MD, PhD, Isao Miyashiro, MD, PhD, Kentaro Kurashina, MD, PhD, Yuki Morooka, RN, MA, Kentaro Kishi, MD, PhD, Alan T. Lefor, MD, MPH

Published in: Annals of Surgical Oncology | Issue 2/2011

Login to get access

Abstract

Background

Quality of life is an important outcome measure in the care of patients with cancer. We developed a new scoring system specifically for the evaluation of patients with upper gastrointestinal cancer and postoperative gastrointestinal dysfunction. This study was undertaken to evaluate the scoring system’s validity in comparing outcomes after gastric resection.

Materials and Methods

Patients with gastric cancer, 3 months to 3 years postoperatively, were surveyed using the survey instrument. Postoperative dysfunction scores and the status of resuming activities of daily living were compared with the surgical procedure performed by analysis of variance and multiple-comparison techniques.

Results

Of 211 patients surveyed, 165 (119 men, 46 women; mean age, 65.1 ± 10.5 years) responded. Procedures included distal gastrectomy in 100, total gastrectomy in 57, and pylorus-preserving gastrectomy in 8. The overall dysfunction score was 61.8 ± 15.5. The dysfunction score was 58.9 ± 15.0 after distal gastrectomy, 66.8 ± 14.1 after total gastrectomy, and 62.4 ± 21.6 after pylorus-preserving gastrectomy. These values differed significantly among the groups (P = .007). Dysfunction scores according to postoperative activity status were 49.1 ± 15.6 in 71 patients who resumed their activities, 56.9 ± 15.7 in 39 patients with reduced activities, 57.3 ± 8.8 in 15 patients with minimal activities, and 63.3 ± 11.8 (P < .05) in 16 patients who did not resume activities because of poor physical condition.

Conclusions

This scoring system for postoperative gastrointestinal dysfunction provides an objective measure of dysfunction related to specific surgical procedures and correlates with activities of daily living in the postoperative period.
Literature
1.
Schipper H, Clinch J, Olweny LM. Definitions and conceptual issues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven; 1996. p. 11–24.
2.
Kapstein A, Morita S, Sakamoto J. Quality of life in gastric cancer. World J Gastroenterol. 2005;11:3189–96.
3.
Nakamura M, Kido Y, Yano M, Hosoya Y. Reliability and validity of a new scale to assess postoperative dysfunction after resection of upper gastrointestinal cancer. Surg Today. 2005;35:535–42.CrossRefPubMed
4.
Dennis A, Revicki MW, Ingela W, Joseph C. Reliability and validity of the gastrointestinal symptom rating scale (GSRS) in patients with gastro oesophageal reflux disease. Qual Life Res. 1998;7:75–83.
5.
DeVellis RF. Scale Development Theory and Application. Newbury Park, CA: Sage Publications; 1991. p. 145–59.
6.
Nakamura M, Kido Y, Hosoya Y, Yano M, Nagai H, Monden M. Postoperative gastrointestinal dysfunction after 2-field versus 3-field lymph node dissection in patients with esophageal cancer. Surg Today. 2007;37:379–82.CrossRefPubMed
7.
Nakamura M, Kido Y, Egawa T. Development of a 32 item scale to assess postoperative dysfunction after upper gastrointestinal cancer resection. J Clin Nurs. 2008;17:1440–9.CrossRefPubMed
8.
Polit DF, Beck CT. Nursing Research: Generating and Assessing Evidence for Nursing Practice. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 2008.
9.
Ronan GF, Senn J, Date A, Maurer L, House K, Carroll J. Personal problem-solving scoring of TAT responses: known-groups validation. J Pers Assess. 1996;67:641–53.CrossRefPubMed
10.
Mitsuno T. Prospects in the treatment of cancer of alimentary organs in relation to rehabilitation (Japanese). In: Ishikawa K, Kimura T, Sano K, editors. Tokyo: Gendaigekagakutaikei Nakayamashoten; 1979. p. 283–302.
11.
Huang CC, Lien HH, Wang PC, Yang JC, Cheng CY, Huang CS. Quality of life in disease-free gastric adenocarcinoma survivors: impacts of clinical stages and constructive surgical procedures. Dig Surg. 2007;24:59–65.CrossRefPubMed
12.
Huang C, Lien H, Sung Y, Liu H, Chie W. Quality of life of patients with gastric cancer in Taiwan: Validation and clinical application of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-STO22. Psycho Oncol. 2007;16:945–9.CrossRef
13.
Onate-Ocana L, Alcantarara-Pilar A, Vilar-Compte D, Garcia-Hubard G, Rojas-Castillo E, Alvarado-Aguilar S, et al. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health related quality of life in patients with gastric cancer. Ann Surg Oncol. 2009;16:88–95.CrossRefPubMed
14.
Jan SV, Ingemar SJ. Gerhard DO. GSRS- a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–34.CrossRef
15.
Hongo M, Fukuhara S, Green J. The evaluation of QOL on gastrointestinal territory- by the Japanese version of GSRS (Japanese). Diag Treatment. 1999;87:731–36.
16.
Kanazaki E. Investigation into the actual for dietary habits and gastrointestinal symptoms the post-gastrectomy after five years (in Japanese). Bull Aichi Junior Coll Nursing. 1992;5:127–35.
17.
Nakamura M. Kido Y. Nursing assignment for gastrointestinal symptoms of post-gastrectomy patient in Japan (in Japanese). Fourth International Nursing Research Conference. Tokyo; 2004. p. 67.
18.
Marcovechio Fonseca CA, Martinez JC, Piesciotto A, Yanagita ET, Denardin OV, Herani Filho B. Manometric study of the lower esophageal sphincter and esophagus in subtotal gastrectomy patients. Dis Esophagus. 2008;21:118–24.CrossRefPubMed
19.
Chan DC, Fan YM, Lin CK, Chen CJ, Chen CY, Chao YC. Roux-en-Y reconstruction after distal gastrectomy to reduce enterogastric reflux and Helicobacter pylori infection. J Gastrointest Surg. 2007;11:1732–40.CrossRefPubMed
20.
Takeshita K, Sekita Y, Tani M. Medium- and long-term results of jejunal pouch reconstruction after a total and proximal gastrectomy. Surg Today. 2007;37:754–61.CrossRefPubMed
21.
Endo S, Nishida T, Nishikawa K, Yumiba T, Nakajima K, Yasumasa K, et al. Motility of the pouch correlates with quality of life after total gastrectomy. Surgery. 2006;139:493–500.CrossRefPubMed
22.
Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y. Analysis of risk factors for the development of gallstones after gastrectomy. Br J Surg. 2005;92:1399–403.CrossRefPubMed
23.
Kono K, Iizuka H, Sekikawa T, Sugai H, Takahashi A, Fujii H, et al. Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg. 2003;185:150–4.CrossRefPubMed
24.
Ishikawa M, Kitayama J, Kaizaki S, Nakayama H, Ishigami H, Fujii S, et al. Prospective randomized trial comparing Billroth I and Roux-en-Y procedures after distal gastrectomy for gastric carcinoma. World J Surg. 2005;29:1415–20.CrossRefPubMed
25.
Iwata T, Kurita N, Ikemoto T, Nishioka M, Andoh T, Shimada M. Evaluation of reconstruction after proximal gastrectomy, prospective comparative study of jejunal interposition and jejunal pouch interposition. Hepatogastroenterology. 2006;53:301–3.
26.
Jentschura D, Winkler M, Strohmeier N, Rumstadt B, Hagmuller E. Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection. Hepatogastroenterology. 1997;44:1137–42.
27.
Davies J, Johnston D, Sue-Ling H, Young S, May J, Griffith J, et al. Total or sub-total gastrectomy for gastric carcinoma? A study of quality of life. World J Surg. 1998;22:1048–55.CrossRefPubMed
28.
Egleston BL, Scharfstein DO and MacKenzie E. On estimation of the survivor average causal effect in observational studies when important confounders are missing due to death. Biometrics. 2009;65:497–504.CrossRefPubMed
29.
Nunobe S, Okaro A, Sasako M, Saka M, Fukagawa T, Katai H, et al. Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. Int J Clin Oncol. 2007;12:433–9.CrossRefPubMed
30.
Nunobe S, Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer. Gastric Cancer. 2007;10:167–72.CrossRefPubMed
Metadata
Title
Extent of Gastric Resection Impacts Patient Quality of Life: The Dysfunction after Upper Gastrointestinal Surgery for Cancer (DAUGS32) Scoring System
Authors
Misuzu Nakamura, RN, PhD
Yoshinori Hosoya, MD, PhD
Masahiko Yano, MD, PhD
Yuichiro Doki, MD, PhD
Isao Miyashiro, MD, PhD
Kentaro Kurashina, MD, PhD
Yuki Morooka, RN, MA
Kentaro Kishi, MD, PhD
Alan T. Lefor, MD, MPH
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1290-y

Other articles of this Issue 2/2011

Annals of Surgical Oncology 2/2011 Go to the issue

Translational Research and Biomarkers

mTOR Signaling is Involved in Indomethacin and Nimesulide Suppression of Colorectal Cancer Cell Growth via a COX-2 Independent Pathway

Thoracic Oncology

Comparison of p53 and Epidermal Growth Factor Receptor Gene Status Between Primary Tumors and Lymph Node Metastases in Non-Small Cell Lung Cancers

Pancreatic Tumors

Invasive IPMN and MCN: Same Organ, Sifferent Outcomes?

Gastrointestinal Oncology

Retrospective Evaluation of the Influence of Postoperative Tumor Marker Status on Survival and Patterns of Recurrence After Surgery for Pancreatic Cancer Based on RECIST Guidelines

Breast Oncology

Resection Margins in Ultrasound-Guided Breast-Conserving Surgery

Melanomas

Sentinel Lymph Node Biopsy: Is It an Evolution of the Management of Cutaneous Melanoma?